Efficacy of entrectinib in patients with NTRK or ROS1 fusion-positive NSCLC with CNS metastases at baseline Meeting Abstract


Authors: Dziadziuszko, R.; Siena, S.; Tan, D. S. W.; Cho, B. C.; Ahn, M. J.; Goto, K.; Garrido-Lopez, P.; Farago, A. F.; Loong, H. H. F.; Tosi, D.; John, T.; Wolf, J.; Chiu, C. H.; Liu, S. V.; Patel, M. R.; Drilon, A.; Pitcher, B.; Simmons, B.; Doebele, R. C.
Abstract Title: Efficacy of entrectinib in patients with NTRK or ROS1 fusion-positive NSCLC with CNS metastases at baseline
Meeting Title: ESMO Virtual Congress 2020
Journal Title: Annals of Oncology
Volume: 31
Issue: Suppl. 4
Meeting Dates: 2020 Sep 19-21/Oct 16-18
Meeting Location: Virtual
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2020-09-01
Start Page: S833
End Page: S834
Language: English
ACCESSION: WOS:000573469101574
DOI: 10.1016/j.annonc.2020.08.1602
PROVIDER: wos
Notes: Meeting Abstract: 1288P -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon